Lead Sponsor

Memorial Sloan Kettering Cancer Center

Age

30 - No limit years

Sex

ALL

Healthy Volunteers

No

•Adult patients (\> 30 years of age) at the time of the initial study visit.
•Patients displaying a phenotype that consists of ≥ 100 nevi on the entire cutaneous surface and at least three large acquired nevi (LAN) \> 5 mm in diameter. These patients have "atypical mole syndrome", which is a high-risk nevus phenotype and the target patient population in this study.
•Patients with at least three clinically stable nevi between 5 and 20 mm in diameter.
•Patients (or LAR) who are able to provide informed consent.
•Patients with previous total body photography images taken at least 3 years prior

•Patients without at least three clinically stable nevi between 5 and 20 mm in diameter.
•Patients with any electronic implantable devices.
•Patients who are pregnant (verbally confirmed with the participant).

Related studies

NCT05171894 · Port-wine Birthmarks, Port-Wine Stain, and more

NCT05463796 · Cancer Risk, Cancer Predisposition Syndrome, and more

NCT06330350 · Quality of Life, Ichthyosis, and more

NCT06605443 · Melanoma (Skin Cancer), Nevi and Melanomas, and more

NCT06934759 · Congenital Melanocytic Nevi, Congenital Melanocytic Nevus, and more

Study of the Nevisense Device to Assess Atypical Skin Lesions